FollowMyHealth Patient Portal

Praveen R. Chenna, MD

Assistant Professor, Medicine
Division of Pulmonary and Critical Care Medicine
Assistant Director of Interventional Pulmonology

Specialty Areas

Pulmonary Disease
Lung Disease
Interventional Pulmonology
Thoracic Oncology

Board Certifications

Internal Medicine
Pulmonary Medicine
Critical Care Medicine

Hospital Affiliations

Barnes-Jewish Hospital

Areas of Clinical Interest

Pulmonary disease with a focus on Interventional pulmonology directed towards: malignant and benign airway disease, lung cancer with advanced diagnostic and therapeutic applications, pleural disease and associated applications for management and treatment.

  • Maps & Directions
  • Education
  • Publication & Research
  • Financial Disclosures

Maps & Directions

Maps & Directions

Center for Advanced Medicine
Lung Center

4921 Parkview Place
St. Louis, MO 63110

Suite: B
Floor: 8
Office Phone: (314) 454-8917
Fax: (314) 747-2200

Education

Education

Fellowship, Interventional Pulmonary Medicine: Washington University School of Medicine, St. Louis, MO 2012
Residency, Internal Medicine: University of Kentucky, Lexington, KY 2008
Medical Degree: Sri Ramachandra Medical College and Research Institute, India 2005
Fellowship, Pulmonary and Critical Care Medicine: University of Kentucky, Lexington, KY 2011
Chief Fellow, Pulmonary and Critical Care Medicine: University of Kentucky, Lexington, KY 2011

Publication & Research

Publication & Research

The use of convex probe endobronchial ultrasound-guided transbronchial needle aspiration in a pediatric population: a multicenter study.
Gilbert CR, Chen A, Akulian JA, Lee HJ, Wahidi M, Argento AC, Tanner NT, Pastis NJ, Harris K, Sterman D, Toth JW, Chenna PR, Feller-Kopman D, Yarmus L
Pediatr Pulmonol. 2014 Aug; 49(8)807-15. doi: 10.1002/ppul.22887.

PMID:
    24039186
    [PubMed - indexed for MEDLINE]
Related citations


Outcomes of severe COPD exacerbations requiring hospitalization.
Chenna PR, Mannino DM
Semin Respir Crit Care Med. 2010 Jun; 31(3)286-94. doi: 10.1055/s-0030-1254069.

PMID:
    20496298
    [PubMed - indexed for MEDLINE]
Related citations

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following financial interests during calendar year 2017:

Company Name: Genentech

Royalties:

Equity: No

Consulting/Advisory Board:

Speaker Fees: $10,000 - $19,999

Reporting Date: May 01, 2018


Company Name: Merck

Royalties:

Equity: No

Consulting/Advisory Board:

Speaker Fees: $10,000 - $19,999

Reporting Date: May 01, 2018

Areas of Research Interest

Advanced Techniques in the diagnosis and management of pleural and lung disease.